Psilocybin - a rapid antidepressant response strategy in depression comorbid with cancer, a randomized, double-blind study, with the possibility to enter to open extension (NW24-04-00413)
Basic information
Investigator: prof. MUDr. Jiří Horáček, Ph.D., FCMA
Main recipient: National Institute of Mental Health (NIMH)
Research period: 1/5/2024 - 31/12/2027
Total budget: 18,244,000 CZK
Supported by: Czech Health Research Council (AZV ČR)
